These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9036095)

  • 1. [Mechanisms of action of intravenous immunoglobulins].
    Poehlau D; Postert T; Rieks M; Baier J; Nastos I; Amoiridis G; Schimrigk S; Hoffmann V; Przuntek H
    Fortschr Med; 1996 Nov; 114(31):420-4. PubMed ID: 9036095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders.
    Ballow M
    J Allergy Clin Immunol; 2011 Feb; 127(2):315-23; quiz 324-5. PubMed ID: 21185071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins induce potentially synergistic immunomodulations in autoimmune disorders.
    Imbach P; Lazarus AH; Kühne T
    Vox Sang; 2010 Apr; 98(3 Pt 2):385-94. PubMed ID: 19821958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Old and current aspects of intravenous immunoglobulin therapy].
    Nydegger U
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):5-25. PubMed ID: 8296191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of intravenous polyclonal immunoglobulins in autoimmune and inflammatory disorders].
    Graff-Dubois S; Sibéril S; Elluru S; Negi VS; Delignat S; Mouthon L; Lacroix-Desmazes S; Kazatchkine MD; Bayary J; Kaveri SV
    Transfus Clin Biol; 2007 May; 14(1):63-8. PubMed ID: 17498995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].
    Gold R; Hartung HP; Toyka KV
    Fortschr Neurol Psychiatr; 1995 Jan; 63(1):17-29. PubMed ID: 7883268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders.
    Emmi L; Chiarini F
    Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins in the therapy of autoimmune and systemic inflammatory disorders.
    Mobini N; Sarela A; Ahmed AR
    Ann Allergy Asthma Immunol; 1995 Feb; 74(2):119-28; quiz 128-33. PubMed ID: 7697470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg?
    Lamoureux J; Aubin E; Lemieux R
    Int Immunol; 2004 Jul; 16(7):929-36. PubMed ID: 15159376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunomodulatory effects of intravenous immunoglobulins].
    Kazatchkine M; Mouthon L; Kaveri SV
    Ann Med Interne (Paris); 2000 May; 151 Suppl 1():1S13-8. PubMed ID: 10896983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of immune modulation in immune thrombocytopenia].
    Wahn V
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():81-5; discussion 86. PubMed ID: 8499756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of infectious antigens and increase of IgG catabolism as possible modes of action of IVIg.
    Masson PL
    J Autoimmun; 1993 Dec; 6(6):683-9. PubMed ID: 8155250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic intravenous immunoglobulins.
    Lemieux R; Bazin R; Néron S
    Mol Immunol; 2005 May; 42(7):839-48. PubMed ID: 15829272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin (IVIg) in the treatment of autoimmune and inflammatory diseases.
    Ruiz de Souza V; Kaveri SV; Kazatchkine MD
    Clin Exp Rheumatol; 1993; 11 Suppl 9():S33-6. PubMed ID: 8354005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intravenous immunoglobulins in autoimmune and inflammatory disorders: beyond a simple substitution].
    Galeotti C; Maddur MS; Kazatchkine MD; Mouthon L; Kaveri SV
    Transfus Clin Biol; 2009 May; 16(2):75-9. PubMed ID: 19443254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose intravenous immunoglobulins: an approach to treat severe immune-mediated and autoimmune diseases of the skin.
    Rütter A; Luger TA
    J Am Acad Dermatol; 2001 Jun; 44(6):1010-24. PubMed ID: 11369915
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous therapy with gamma globulin.
    Dwyer JM
    Adv Intern Med; 1987; 32():111-35. PubMed ID: 3548246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Current applications of immunoglobulin therapy].
    Helmke K
    Fortschr Med; 1994 May; 112(15):213-7. PubMed ID: 8050765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous immunoglobulin: an emerging treatment for immune-mediated skin diseases.
    Rütter A; Luger TA
    Curr Opin Investig Drugs; 2002 May; 3(5):713-9. PubMed ID: 12090544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.